OOIR: Observatory of International Research

Papers

(The H4-Index of Translational Oncology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Global colorectal cancer burden in 2020 and projections to 2040	1207
Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis	133
Early lung cancer diagnostic biomarker discovery by machine learning methods	130
NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis	114
3D Bioprinted cancer models: Revolutionizing personalized cancer therapy	109
Plasticity of cancer cell invasion: Patterns and mechanisms	109
The interaction mechanism between autophagy and apoptosis in colon cancer	86
Influence of cholesterol on cancer progression and therapy	79
The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles	72
HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases	70
Extracellular heat shock proteins and cancer: New perspectives	67
The remodelling of actin composition as a hallmark of cancer	66
Chlorogenic acid: Potential source of natural drugs for the therapeutics of fibrosis and cancer	61
Regulation of CD47 expression in cancer cells	56
Therapeutic approaches for the treatment of head and neck squamous cell carcinoma–An update on clinical trials	56
Targeting cancer-cell mitochondria and metabolism to improve radiotherapy response	50
PLK1 inhibition-based combination therapies for cancer management	49
Etoposide, an anticancer drug involved in therapy-related secondary leukemia: Enzymes at play	46
Using deep learning to predict anti-PD-1 response in melanoma and lung cancer patients from histopathology images	45
Drug screening model meets cancer organoid technology	44
Recent advances in the field of single-cell proteomics	42
Resistin: A journey from metabolism to cancer	41
Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes	41
Mesenchymal stem/stromal cells: Developmental origin, tumorigenesis and translational cancer therapeutics	39
The spontaneous remission of cancer: Current insights and therapeutic significance	39

Combination therapy: Future directions of immunotherapy in small cell lung cancer	38
Hypoxia-induced therapy resistance: Available hypoxia-targeting strategies and current advances in head and neck cancer	37
Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine	37
Iron (Fe)-doped mesoporous 45S5 bioactive glasses: Implications for cancer therapy	36
Three-dimensional organoid culture unveils resistance to clinical therapies in adult and pediatric glioblastoma	36
The current landscape of the FDA approved companion diagnostics	35
m6A demethylase FTO renders radioresistance of nasopharyngeal carcinoma via promoting OTUB1-mediated anti-ferroptosis	35
Transition metal ion-doped ferrites nanoparticles for bioimaging and cancer therapy	34
Hsa_circ_0092276 promotes doxorubicin resistance in breast cancer cells by regulating autophagy via miR-348/ATG7 axis	34
Long non-coding RNAs in cancer stem cells	34